Company Filing History:
Years Active: 2014-2016
Title: The Innovative Contributions of Andreas Steffen
Introduction
Andreas Steffen is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target diseases characterized by excessive or abnormal cell proliferation. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Steffen's latest patents include innovative compounds such as Triazolopyridazine. This patent discloses compounds of general formula (I), wherein the groups R to R have specific meanings as outlined in the claims and specification. These compounds are particularly suitable for treating diseases associated with excessive or abnormal cell proliferation. Another significant patent is for 6-alkynylpyridines, which are identified as SMAC mimetics. These compounds are also useful as medicaments for treating conditions like cancer, which are characterized by abnormal cell growth.
Career Highlights
Andreas Steffen is currently associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company focuses on developing innovative solutions for complex medical challenges. His contributions have been instrumental in advancing research in the pharmaceutical industry.
Collaborations
Steffen has collaborated with esteemed colleagues such as Ulrich Reiser and Gerd Bader. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.
Conclusion
Andreas Steffen's innovative work in pharmaceuticals, particularly in the area of abnormal cell proliferation, showcases his commitment to advancing medical science. His patents reflect a dedication to improving treatment options for serious health conditions.